HK Stock MarketDetailed Quotes

03759 PHARMARON

Watchlist
  • 13.340
  • +0.340+2.62%
Market Closed Nov 29 16:08 CST
23.84BMarket Cap11.41P/E (TTM)

PHARMARON Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Turnover
3.00%8.82B
-0.63%5.6B
-1.95%2.67B
12.39%11.54B
15.64%8.56B
21.70%5.64B
29.53%2.72B
37.92%10.27B
39.63%7.4B
41.06%4.63B
Operating income
3.00%8.82B
-0.63%5.6B
-1.95%2.67B
12.39%11.54B
15.64%8.56B
21.70%5.64B
29.53%2.72B
37.92%10.27B
39.63%7.4B
41.06%4.63B
Cost of sales
----
-4.27%-3.76B
----
-14.21%-7.44B
----
-19.24%-3.6B
----
-36.58%-6.52B
----
-44.17%-3.02B
Operating expenses
-6.36%-5.83B
-4.27%-3.76B
-2.84%-1.8B
-14.21%-7.44B
-16.60%-5.48B
-19.24%-3.6B
-24.28%-1.75B
-36.58%-6.52B
-39.81%-4.7B
-44.17%-3.02B
Gross profit
-2.97%2.99B
-9.30%1.85B
-10.55%872.15M
9.22%4.09B
13.95%3.08B
26.31%2.04B
40.16%974.97M
40.31%3.75B
39.34%2.7B
35.59%1.61B
Selling expenses
3.80%-186.56M
3.02%-122.95M
0.41%-55.47M
-9.87%-252.78M
-18.94%-193.92M
-17.27%-126.78M
-18.95%-55.7M
-47.84%-230.07M
-56.20%-163.04M
-69.63%-108.11M
Administrative expenses
0.62%-1.21B
0.50%-841.22M
3.81%-398.61M
-7.75%-1.67B
-17.15%-1.21B
-27.89%-845.44M
-42.63%-414.38M
-70.85%-1.55B
-73.19%-1.04B
-72.34%-661.07M
Research and development expenses
-11.96%-332.25M
-14.06%-207.8M
-21.82%-93.61M
-58.78%-448.28M
-67.22%-296.76M
-117.74%-182.18M
-93.81%-76.84M
-86.02%-282.33M
-61.55%-177.47M
-29.79%-83.67M
Profit from asset sales
-9,732.09%-23.92M
----
-17,640.70%-20M
----
118.51%248.31K
----
124.01%114K
----
-17.65%-1.34M
----
Revaluation surplus
-155.03%-22.12M
----
-103.94%-1.13M
----
-48.12%40.2M
----
-36.42%28.58M
----
328.45%77.49M
----
-Changes in the fair value of other assets
-155.03%-22.12M
----
-103.94%-1.13M
----
-48.12%40.2M
----
-36.42%28.58M
----
328.45%77.49M
----
Impairment and provision
-25.70%-29.68M
-114.13%-22.94M
-48.33%-6.47M
-69.33%-35.83M
-95.17%-23.61M
-69.00%-10.71M
-1,025.65%-4.36M
-106.03%-21.16M
-82.15%-12.1M
-1,443.01%-6.34M
-Other impairment is provision
-25.70%-29.68M
-114.13%-22.94M
-48.33%-6.47M
-69.33%-35.83M
-95.17%-23.61M
-69.00%-10.71M
-1,025.65%-4.36M
-106.03%-21.16M
-82.15%-12.1M
-1,443.01%-6.34M
Operating interest expense
----
----
----
----
----
----
----
----
----
-414.60%-81.24M
Special items of operating profit
521.30%659.56M
549.74%742.27M
81.86%64.63M
65.17%336.11M
132.75%106.16M
53.44%114.24M
210.94%35.54M
-57.25%203.49M
-72.56%45.61M
623.82%74.45M
Operating profit
22.45%1.76B
41.44%1.4B
-29.53%331.85M
8.28%2.02B
3.79%1.44B
32.05%986.57M
30.70%470.91M
1.54%1.87B
13.73%1.38B
11.03%747.14M
Financing cost
-21.96%-132.74M
-55.29%-138.25M
-61.25%-63.44M
-8.89%-182.19M
32.76%-108.84M
---89.03M
2.22%-39.34M
---167.31M
-1,282.67%-161.87M
----
Share of profits of associates
----
-375.96%-30.31M
----
93.84%-2.08M
----
347.40%10.98M
----
-147.12%-33.85M
----
36.52%-4.44M
Special items of earning before tax
28.90%-5.36M
----
104.11%204.32K
----
51.46%-7.54M
----
-27.90%-4.97M
----
-349.98%-15.53M
----
Earning before tax
22.78%1.62B
35.04%1.23B
-37.03%268.62M
10.29%1.84B
9.40%1.32B
22.33%908.53M
34.92%426.6M
-12.80%1.67B
0.41%1.21B
11.53%742.7M
Tax
-35.54%-252.67M
-15.63%-143.91M
31.07%-52.7M
18.50%-256.11M
29.20%-186.42M
29.84%-124.46M
3.50%-76.45M
-8.02%-314.25M
-32.55%-263.29M
-49.56%-177.4M
After-tax profit from continuing operations
20.69%1.37B
38.12%1.08B
-38.33%215.92M
16.98%1.58B
20.16%1.13B
38.70%784.07M
47.77%350.15M
-16.54%1.35B
-5.95%944.18M
3.29%565.3M
Earning after tax
20.69%1.37B
38.12%1.08B
-38.33%215.92M
16.98%1.58B
20.16%1.13B
38.70%784.07M
47.77%350.15M
-16.54%1.35B
-5.95%944.18M
3.29%565.3M
Minority profit
-1,064.87%-52.59M
-1,404.05%-30.46M
-873.86%-14.64M
14.03%-19.32M
73.33%-4.51M
89.94%-2.03M
115.59%1.89M
45.14%-22.47M
53.15%-16.93M
-14.80%-20.13M
Profit attributable to shareholders
24.82%1.42B
41.64%1.11B
-33.80%230.56M
16.48%1.6B
18.51%1.14B
34.28%786.09M
39.81%348.26M
-17.24%1.37B
-7.59%961.11M
3.65%585.43M
Basic earnings per share
24.85%0.8028
41.42%0.6282
-33.94%0.13
16.55%0.9033
18.81%0.643
-10.10%0.4442
-6.42%0.1968
-44.60%0.775
-38.18%0.5412
4.00%0.4941
Diluted earnings per share
24.89%0.8019
41.37%0.6271
-34.01%0.1298
16.54%0.9019
18.75%0.6421
-10.18%0.4436
-6.29%0.1967
-43.47%0.7739
-38.11%0.5407
4.04%0.4939
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
Auditor
--
--
--
Ernst & Young
--
--
--
Ernst & Young
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Turnover 3.00%8.82B-0.63%5.6B-1.95%2.67B12.39%11.54B15.64%8.56B21.70%5.64B29.53%2.72B37.92%10.27B39.63%7.4B41.06%4.63B
Operating income 3.00%8.82B-0.63%5.6B-1.95%2.67B12.39%11.54B15.64%8.56B21.70%5.64B29.53%2.72B37.92%10.27B39.63%7.4B41.06%4.63B
Cost of sales -----4.27%-3.76B-----14.21%-7.44B-----19.24%-3.6B-----36.58%-6.52B-----44.17%-3.02B
Operating expenses -6.36%-5.83B-4.27%-3.76B-2.84%-1.8B-14.21%-7.44B-16.60%-5.48B-19.24%-3.6B-24.28%-1.75B-36.58%-6.52B-39.81%-4.7B-44.17%-3.02B
Gross profit -2.97%2.99B-9.30%1.85B-10.55%872.15M9.22%4.09B13.95%3.08B26.31%2.04B40.16%974.97M40.31%3.75B39.34%2.7B35.59%1.61B
Selling expenses 3.80%-186.56M3.02%-122.95M0.41%-55.47M-9.87%-252.78M-18.94%-193.92M-17.27%-126.78M-18.95%-55.7M-47.84%-230.07M-56.20%-163.04M-69.63%-108.11M
Administrative expenses 0.62%-1.21B0.50%-841.22M3.81%-398.61M-7.75%-1.67B-17.15%-1.21B-27.89%-845.44M-42.63%-414.38M-70.85%-1.55B-73.19%-1.04B-72.34%-661.07M
Research and development expenses -11.96%-332.25M-14.06%-207.8M-21.82%-93.61M-58.78%-448.28M-67.22%-296.76M-117.74%-182.18M-93.81%-76.84M-86.02%-282.33M-61.55%-177.47M-29.79%-83.67M
Profit from asset sales -9,732.09%-23.92M-----17,640.70%-20M----118.51%248.31K----124.01%114K-----17.65%-1.34M----
Revaluation surplus -155.03%-22.12M-----103.94%-1.13M-----48.12%40.2M-----36.42%28.58M----328.45%77.49M----
-Changes in the fair value of other assets -155.03%-22.12M-----103.94%-1.13M-----48.12%40.2M-----36.42%28.58M----328.45%77.49M----
Impairment and provision -25.70%-29.68M-114.13%-22.94M-48.33%-6.47M-69.33%-35.83M-95.17%-23.61M-69.00%-10.71M-1,025.65%-4.36M-106.03%-21.16M-82.15%-12.1M-1,443.01%-6.34M
-Other impairment is provision -25.70%-29.68M-114.13%-22.94M-48.33%-6.47M-69.33%-35.83M-95.17%-23.61M-69.00%-10.71M-1,025.65%-4.36M-106.03%-21.16M-82.15%-12.1M-1,443.01%-6.34M
Operating interest expense -------------------------------------414.60%-81.24M
Special items of operating profit 521.30%659.56M549.74%742.27M81.86%64.63M65.17%336.11M132.75%106.16M53.44%114.24M210.94%35.54M-57.25%203.49M-72.56%45.61M623.82%74.45M
Operating profit 22.45%1.76B41.44%1.4B-29.53%331.85M8.28%2.02B3.79%1.44B32.05%986.57M30.70%470.91M1.54%1.87B13.73%1.38B11.03%747.14M
Financing cost -21.96%-132.74M-55.29%-138.25M-61.25%-63.44M-8.89%-182.19M32.76%-108.84M---89.03M2.22%-39.34M---167.31M-1,282.67%-161.87M----
Share of profits of associates -----375.96%-30.31M----93.84%-2.08M----347.40%10.98M-----147.12%-33.85M----36.52%-4.44M
Special items of earning before tax 28.90%-5.36M----104.11%204.32K----51.46%-7.54M-----27.90%-4.97M-----349.98%-15.53M----
Earning before tax 22.78%1.62B35.04%1.23B-37.03%268.62M10.29%1.84B9.40%1.32B22.33%908.53M34.92%426.6M-12.80%1.67B0.41%1.21B11.53%742.7M
Tax -35.54%-252.67M-15.63%-143.91M31.07%-52.7M18.50%-256.11M29.20%-186.42M29.84%-124.46M3.50%-76.45M-8.02%-314.25M-32.55%-263.29M-49.56%-177.4M
After-tax profit from continuing operations 20.69%1.37B38.12%1.08B-38.33%215.92M16.98%1.58B20.16%1.13B38.70%784.07M47.77%350.15M-16.54%1.35B-5.95%944.18M3.29%565.3M
Earning after tax 20.69%1.37B38.12%1.08B-38.33%215.92M16.98%1.58B20.16%1.13B38.70%784.07M47.77%350.15M-16.54%1.35B-5.95%944.18M3.29%565.3M
Minority profit -1,064.87%-52.59M-1,404.05%-30.46M-873.86%-14.64M14.03%-19.32M73.33%-4.51M89.94%-2.03M115.59%1.89M45.14%-22.47M53.15%-16.93M-14.80%-20.13M
Profit attributable to shareholders 24.82%1.42B41.64%1.11B-33.80%230.56M16.48%1.6B18.51%1.14B34.28%786.09M39.81%348.26M-17.24%1.37B-7.59%961.11M3.65%585.43M
Basic earnings per share 24.85%0.802841.42%0.6282-33.94%0.1316.55%0.903318.81%0.643-10.10%0.4442-6.42%0.1968-44.60%0.775-38.18%0.54124.00%0.4941
Diluted earnings per share 24.89%0.801941.37%0.6271-34.01%0.129816.54%0.901918.75%0.6421-10.18%0.4436-6.29%0.1967-43.47%0.7739-38.11%0.54074.04%0.4939
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)IASCAS (2007)IASCAS (2007)IASCAS (2007)IASCAS (2007)IAS
Audit Opinions ------Unqualified Opinion------Unqualified Opinion----
Auditor ------Ernst & Young------Ernst & Young----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data